Table 1.
Gene symbol | Shai brain | Murat brain | Brendel brain 2 | |||
---|---|---|---|---|---|---|
Fold change (GBM/Normal brain) | P | Fold change (GBM/Normal brain) | P | Fold change (GBM/Normal brain) | P | |
NHP2L1 | N/A | N/A | 1.198 | 0.006 | −2.08 | 1 |
PSMB2 | 2.068 | <0.001 | 1.541 | 0.007 | 1.448 | 0.001 |
PSMD1 | 1.226 | 0.006 | −1.328 | 0.98 | −1.001 | 0.501 |
RAN | 3.375 | <0.001 | 1.265 | <0.001 | 1.512 | 0.004 |
RPL23A | 1.714 | 0.006 | 1.193 | <0.001 | N/A | N/A |
RPS13 | 1.37 | 0.003 | 1.358 | 0.014 | 1.278 | 0.012 |
RPS15A | 1.617 | <0.001 | 1.985 | <0.001 | 1.916 | <0.001 |
RPS7 | 1.928 | <0.001 | 1.4 | <0.001 | 1.161 | 0.077 |
UBB | −1.002 | 0.505 | −1.252 | 0.992 | −1.642 | 0.994 |
KPNB1 | 1.37 | <0.001 | 1.171 | <0.001 | 1.098 | 0.009 |
KPNA2 | 2.063 | <0.001 | 1.67 | <0.001 | 1.608 | 0.003 |
Data were retrieved from the Oncomine database. mRNA fold changes (GBM/normal brain) and P-values that determine the significance of fold changes are shown. Positive numbers indicate more mRNAs in GBM and negative numbers indicate less mRNA in GBM. Candidates showing significantly high levels in GBM in all three studies are highlighted in red.